Cargando…

T Cell Co-Stimulation: Inhibition of Immunosuppression?

Detalles Bibliográficos
Autor principal:	Sundqvist, Karl-Gösta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943593/ https://www.ncbi.nlm.nih.gov/pubmed/29774033 http://dx.doi.org/10.3389/fimmu.2018.00974

Ejemplares similares

T Cell Motility─How Is It Regulated?
por: Sundqvist, Karl-Gösta
Publicado: (2020)

CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade
por: Sundqvist, Karl-Gösta
Publicado: (2021)

CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
por: Fortunato, Orazio, et al.
Publicado: (2020)

Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment
por: Cruz Cruz, Joselyn, et al.
Publicado: (2023)

Defective Chemokine Production in T-Leukemia Cell Lines and its Possible Functional Role
por: Ivanoff, Jyrki, et al.
Publicado: (2000)

The Molecular Mechanisms of Regulatory T Cell Immunosuppression
por: Pandiyan, Pushpa, et al.
Publicado: (2011)

The molecular mechanisms of regulatory T cell immunosuppression
por: Smith, Kendall A.
Publicado: (2012)

Immunosuppressive Mechanisms of Regulatory B Cells
por: Catalán, Diego, et al.
Publicado: (2021)

The Role of Myeloid Cells in GBM Immunosuppression
por: Lin, Ya-Jui, et al.
Publicado: (2022)

Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro
por: Pradier, Amandine, et al.
Publicado: (2019)

Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
por: Favalli, Andrea, et al.
Publicado: (2022)

Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
por: Ma, Qianquan, et al.
Publicado: (2018)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
por: Lin, Aifen, et al.
Publicado: (2021)

Androgen-Induced Immunosuppression
por: Gubbels Bupp, Melanie R., et al.
Publicado: (2018)

Immunosuppressive Property of MSCs Mediated by Cell Surface Receptors
por: Liu, Siyu, et al.
Publicado: (2020)

Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
por: Xia, Yidan, et al.
Publicado: (2022)

Efficient complement-mediated clearance of immunosuppressed T cells by macrophages
por: Gankema, Angela A. F., et al.
Publicado: (2023)

B lymphocytes transdifferentiate into immunosuppressive erythroblast-like cells
por: Yang, Zhe, et al.
Publicado: (2023)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
por: Zhang, Yuzhuo, et al.
Publicado: (2022)

Editorial: Immunosuppressive disease in poultry
por: Li, Charles, et al.
Publicado: (2023)

T Follicular Helper Cells As a New Target for Immunosuppressive Therapies
por: Yan, Lin, et al.
Publicado: (2017)

Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
por: Bai, Yi, et al.
Publicado: (2022)

Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes
por: Herzig, Maryanne C., et al.
Publicado: (2023)

Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
por: Mohapatra, Soumya R., et al.
Publicado: (2019)

Intervention of PKC-θ as an immunosuppressive regimen
por: Sun, Zuoming
Publicado: (2012)

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
por: DeCordova, Syreeta, et al.
Publicado: (2020)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Functions and mechanisms of lactylation in carcinogenesis and immunosuppression
por: Su, Jing, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
por: Baert, Thaïs, et al.
Publicado: (2019)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

CD1d-independent NK1.1(+) Treg cells are IL2-inducible Foxp3(+) T cells co-expressing immunosuppressive and cytotoxic molecules
por: Park, Hyun Jung, et al.
Publicado: (2022)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2021)

Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
por: Sahoo, Sarthak, et al.
Publicado: (2021)

Case Report: Azathioprine: An Old and Wronged Immunosuppressant
por: Chocair, Pedro R., et al.
Publicado: (2022)

Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia
por: Bouras, Marwan, et al.
Publicado: (2018)

Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
por: Fu, Weilun, et al.
Publicado: (2020)

T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages
por: Torres, Gretel M., et al.
Publicado: (2022)

Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
por: Blaye, Céline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sp6dhn0j0t0t85tq27tojmut0b